Resolian Acquires China-Based Bioanalytical CRO Denali Medpharma

MALVERN, Pa. & CHONGQING, China–(BUSINESS WIRE)–Nov. 01, 2023 Resolian, a global bioanalytical contract research organization (CRO) specializing in drug metabolism and pharmacokinetics for small and large molecules, has acquired Denali Medpharma, a leading China-based bioanalytical CRO. Resolian now has bioanalysis laboratory operations in the U.S., U.K., Australia, and China. The company can initiate a project […]

Medisca Expands Strategic Partnerships to Drive Patient Access to Critical Medications

MONTREAL–(BUSINESS WIRE)–Jul. 27, 2023 Medisca has announced the expansion of a network of strategic partnerships aimed at securing and stabilizing worldwide access to high quality active pharmaceutical ingredients (APIs) for the preparation of essential medications. This mission started with the exclusive partnership for Thyroid USP in 2021, and has now expanded to include Progesterone USP […]

China Industry-University-Research-Medicine Shines at the Top of the World: BOTANEE 2023 International Skin Health Summit Closed

SINGAPORE–(BUSINESS WIRE)–Jul. 12, 2023 "In 2015, we made our first appearance in Vancouver WCD with the main brand WINONA. After eight years, WINONA has now become the leading brand of functional skin care products in China. Invited to participate in WCD for three times this year, we brought four core brands. I hope that after […]

SciMed (Asia) Life Science Sales and Service Distributing Subsidiary of PHC Holdings Corporation Becomes Wholly Owned Subsidiary — Acquisition Expands PHC Group’s Business Supporting Researchers and Healthcare Providers in Asia-Pacific —

TOKYO–(BUSINESS WIRE)–Jun. 15, 2023 PHC Holdings Corporation (headquarters: Minato-ku, Tokyo, Japan, President, Representative Director and CEO: Shoji Miyazaki, hereafter PHCHD) announces that it has acquired the remaining 30% stake in its subsidiary SciMed (Asia) Pte. Ltd. (headquarters: Singapore, hereafter SciMed), making SciMed a wholly owned subsidiary of PHCHD. PHCHD previously owned a 70% stake in […]

ANANDA Scientific Announces First Patient Enrolled in FDA-approved Clinical Trial Evaluating a Potential New Treatment for Social Anxiety Disorder (SAD)

NEW YORK & GREENWOOD VILLAGE, Colo.–(BUSINESS WIRE)–Mar. 28, 2023 ANANDA Scientific Inc., a research focused bio-pharmaceutical company today announced that the first subject has been enrolled in the clinical trial with an FDA-approved IND evaluating Nantheia™ A1002N5S, an investigational drug using cannabidiol (CBD) in ANANDA’s proprietary Liquid Structure™ delivery technology as a potential treatment for […]

‘Medical Korea 2023 Conference’ on Global Medical Industry Prospects to Kick off on March 23 at Coex

SEOUL, South Korea–(BUSINESS WIRE)–Mar. 22, 2023 The Ministry of Health and Welfare (MOHW) and the Korea Health Industry Development Institute (KHIDI) will host Medical Korea 2023 – The 13th Global Healthcare & Medical Tourism Conference at Coex in Seoul from March 23 (Thu) to March 24 (Fri), 2023. This press release features multimedia. View the […]

University of Nebraska Medical Center and ANANDA Scientific announce First Patient Enrolled in FDA-approved clinical trial for Post-Traumatic Stress Disorder (PTSD)

OMAHA, Neb. & GREENWOOD VILLAGE, Colo.–(BUSINESS WIRE)–Mar. 14, 2023 The University of Nebraska Medical Center (UNMC) and ANANDA Scientific Inc. today announced that the first patient has been enrolled in an FDA-approved clinical trial evaluating Nantheia™ ATL5, an investigational drug using cannabidiol in ANANDA’s proprietary Liquid Structure™ delivery technology, for Post-Traumatic Stress Disorder (PTSD). (Clinical […]

Medidata Drives Diversity in Clinical Trials Passing 30 000 Studies and 9 Million Participants

Unprecedented industry milestones achieved with continuous innovation supporting the digital transformation of life sciences NEW YORK–(BUSINESS WIRE)–Mar. 02, 2023 Known for its ground-breaking technological innovations in clinical trials, Medidata, a Dassault Systèmes company, has exceeded 30,000 clinical trials and 9 million study participants. These milestones, achieved together with more than 2,100 global customers and partners, have […]

Dexcom G6 Continuous Glucose Monitoring System Launches in Singapore

Innovative new CGM system eliminates routine fingersticks for people with diabetes SINGAPORE–(BUSINESS WIRE)–Feb. 28, 2023 Dexcom, Inc. (NASDAQ:DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the launch of its Dexcom G6 CGM System in Singapore for people with diabetes ages two years and older, including pregnant women, […]

Global talent leader WilsonHCG acquires Personify to further expand its healthcare and life sciences talent solutions

TAMPA, Fla.–(BUSINESS WIRE)–Jan. 11, 2023 WilsonHCG, a global talent leader, has announced the acquisition of Personify, an award-winning recruitment process outsourcing (RPO) provider. Personify specializes in the life sciences, healthcare, biotech and pharmaceuticals sectors and other industries experiencing critical skills shortages. Personify, a leader in its core markets, provides executive search and recruitment marketing services […]